A rare case of concomitant Lambert–Eaton myasthenic syndrome and syndrome of inappropriate antidiuretic hormone secretion in a patient with small cell lung carcinoma

Lang, 1983, Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse, J. Physiol., 344, 335, 10.1113/jphysiol.1983.sp014943 Titulaer, 2011, Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies, Lancet Neurol., 10, 1098, 10.1016/S1474-4422(11)70245-9 Nakao, 2002, Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients, Neurology, 59, 1773, 10.1212/01.WNL.0000037485.56217.5F Yoshikawa, 2022, Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan, BMJ Neurol Open, 4, 10.1136/bmjno-2022-000291 Mentrasti, 2020, Syndrome of inappropriate antidiuretic hormone secretion (SIADH): optimal management, Therapeut. Clin. Risk Manag., 16, 663, 10.2147/TCRM.S206066 Kanaji, 2014, Paraneoplastic syndromes associated with lung cancer, World J. Clin. Oncol., 5, 197, 10.5306/wjco.v5.i3.197 Fiordoliva, 2017, Managing hyponatremia in lung cancer: latest evidence and clinical implications, Ther. Adv. Med. Oncol., 9, 711, 10.1177/1758834017736210 Spiro, 2007, Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition), Chest, 132, 149S, 10.1378/chest.07-1358 Ellison, 2007, Clinical practice. The syndrome of inappropriate antidiuresis, N. Engl. J. Med., 356, 2064, 10.1056/NEJMcp066837 Kobayashi, 2011, [A case of small-cell lung carcinoma accompanied by the syndrome of inappropriate secretion of antidiuretic hormone and Lambert-Eaton myasthenic syndrome], Nihon Kokyuki Gakkai Zasshi, 49, 197 Manji, 1990, Lambert Eaton syndrome: autonomic neuropathy and inappropriate antidiuretic hormone secretion in a patient with small cell carcinoma of the lung, J. Neurol., 237, 324, 10.1007/BF00314753 Riva, 1997, Immunological and endocrinological abnormalities in paraneoplastic disorders with involvement of the autonomic nervous system, Ital. J. Neurol. Sci., 18, 157, 10.1007/BF02048484 Honoki, 2003, [Marked improvement of Lambert-Eaton myasthenic syndrome resulting from treatment for small cell lung carcinoma], Nihon Kokyuki Gakkai Zasshi, 41, 331 Liu, 2023, Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: a real-world study of 612 cases with eastern cooperative oncology group performance score 0-1, Cancer Med., 12, 9527, 10.1002/cam4.5728 Maddison, 2017, Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome, Neurology, 88, 1334, 10.1212/WNL.0000000000003794 Castillo, 2012, Diagnosis and management of hyponatremia in cancer patients, Oncol., 17, 756, 10.1634/theoncologist.2011-0400 Maddison, 1998, Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome, J. Neurol. Neurosurg. Psychiatry, 65, 213, 10.1136/jnnp.65.2.213 Mason, 1997, Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome, Brain, 120, 1279, 10.1093/brain/120.8.1279 Wang, 2006, Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer, Clin. Lung Cancer, 7, 282, 10.3816/CLC.2006.n.008 Chalk, 1990, Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma, Neurology, 40, 1552, 10.1212/WNL.40.10.1552